EN
No verificado

ENDRA Life Sciences Inc.

Sobre qué escribimos

CienciaMaterial médico sanitarioMedicina - VariosMedicina nuclearSalud
17/07/2026
Material médico sanitario
Salud
Materias primas
Energía
Energía nuclear
Eventos
Join the Live Investor Webinar for Noble Africa, the Proposed ASP Isotopes Spin-Out Creating a Public Helium Company
1.00
25/06/2026
Mercado de valores
Materias primas
Salud
Energía
Material médico sanitario
Energía nuclear
ASP Isotopes Announces Proposed Merger of Noble Africa with ENDRA Life Sciences and Approximately $50 Million Concurrent Private Placement Financing
1.00
18/05/2026
Mercado de valores
Industria
Ciencia
Material médico sanitario
Medicina - Varios
Biotecnología
Medicina nuclear
Salud
Farmacéutica
ENDRA Life Sciences Reports First Quarter 2026 Financial Results and Provides Business Update
1.00
14/05/2026
Industria
Salud
Material médico sanitario
Medicina - Varios
Ciencia
Farmacéutica
ENDRA Life Sciences Reports Multi-Site Validation of TAEUS® Liver Device Demonstrating MRI-like Accuracy and Reproducibility
1.00
31/03/2026
Mercado de valores
Material médico sanitario
Salud
Medicina - Varios
Sanidad
Medicina nuclear
ENDRA Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
1.00
25/03/2026
Salud
Material médico sanitario
Técnica
Tecnología
Sanidad
Biotecnología
ENDRA Life Sciences Initiates Review of Strategic Alternatives to Maximize Shareholder Value
1.00
26/02/2026
Industria
Ciencia
Material médico sanitario
Biotecnología
Medicina - Varios
Medicina nuclear
Farmacéutica
Salud
ENDRA’s TAEUS® Liver Device Demonstrates High-Level Consistency in Clinical Study, Delivering MRI-Level Results at the Point of Patient Care
1.00
20/11/2025
Industria
Ciencia
Medicina nuclear
Biotecnología
Salud
Material médico sanitario
Medicina - Varios
ENDRA Feasibility Study Demonstrates TAEUS® Accurately Quantifies Liver Fat Fraction, a Key MASLD/MASH Biomarker
1.00
17/11/2025
Salud
Sanidad
Medicina - Varios
Ciencia
Biotecnología
Mercado de valores
ENDRA Life Sciences Recaps Major Milestones and New Strategic Initiatives, Announces Third Quarter 2025 Financial Results
1.00

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0